{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:04:47Z","timestamp":1791043487242,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/adm.0b013e318293655a","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T10:40:21Z","timestamp":1368182421000},"page":"264-270","source":"Crossref","is-referenced-by-count":32,"title":["Interactions Between Alcohol and the Antiretroviral Medications Ritonavir or Efavirenz"],"prefix":"10.1097","volume":"7","author":[{"given":"Elinore F.","family":"McCance-Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrie M.","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2007-1007344","article-title":"Genetic factors in alcohol metabolism and alcoholism.","volume":"13","author":"Bosron","year":"1993","journal-title":"Semin Liver Dis"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/09540120601095734","article-title":"Estimating the impact of alcohol consumption on survival for HIV individuals.","volume":"19","author":"Braithwaite","year":"2007","journal-title":"AIDS Care"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.qai.0000243121.44659.a4","article-title":"Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.","volume":"43","author":"Chander","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1525-1497.2001.00122.x","article-title":"Problem drinking and medication adherence among persons with HIV infection.","volume":"16","author":"Cook","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0149-2918(02)80058-3","article-title":"Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.","volume":"24","author":"Fung","year":"2002","journal-title":"Clin Ther"},{"issue":"2","key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181b18b6e","article-title":"Alcohol use and antiretroviral adherence: review and meta-analysis.","volume":"52","author":"Hendershot","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jana.2011.11.005","article-title":"Alcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV.","volume":"23","author":"Kalichman","year":"2012","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"3","key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11606-012-2231-1","article-title":"Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.","volume":"28","author":"Kalichman","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3565(25)12840-1","article-title":"Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.","volume":"277","author":"Kumar","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(99)00021-6","article-title":"Transport, metabolism and elimination mechanisms of anti-HIV agents.","volume":"39","author":"Li","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00019616-199403000-00009","article-title":"Metabolic consequences of ethanol.","volume":"4","author":"Lieber","year":"1994","journal-title":"Endocrinologist"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1081\/DMR-200033441","article-title":"The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.","volume":"36","author":"Lieber","year":"2004","journal-title":"Drug Metab Rev"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-3223(97)00426-5","article-title":"Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either drug alonea multiple dose study.","volume":"44","author":"McCance-Katz","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"3","key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/QAI.0b013e318256625f","article-title":"Untreated HIV infection is associated with higher blood alcohol levels.","volume":"60","author":"McCance-Katz","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02257405","article-title":"Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior and the role of cocaethylene.","volume":"111","author":"McCance-Katz","year":"1993","journal-title":"Psychopharmacology"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2004.00194.x","article-title":"Pharmacokinetics of emtricitabine, didanosine, and efavirenz administered once daily as treatment for HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).","volume":"5","author":"Molina","year":"2004","journal-title":"HIV Med"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/dmd.104.002931","article-title":"Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.","volume":"33","author":"Perloff","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.ALC.0000122103.74491.78","article-title":"Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.","volume":"28","author":"Samet","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP 2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIVAIDS therapy and utility of efavirenz as a substrate marker of CYP 2B6 catalytic activity.","volume":"306","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0b013e318293655a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:30:39Z","timestamp":1746005439000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201307000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e318293655a","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}